What Is Abeona Therapeutics Inc. (ABEO) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Abeona Therapeutics Inc.'s intrinsic value is estimated at $3.61, suggesting the stock is overvalued at its current price of $7.29. With 9 out of 12 models flagging downside (-50.4% average return), the market may be pricing in unsustainable growth. The most optimistic model, FTNN, places fair value at $11.13 (+52.6%), while EPV — the most conservative — estimates $0.85 (-88.4%). This +141.0% gap reflects genuine analytical uncertainty about Abeona Therapeutics Inc.'s intrinsic worth.
What Do the Models Say About ABEO?
12 of 13 models are currently active for ABEO. Of these, 2 models suggest upside while 10 models suggest overvaluation. The Bayesian DCF estimates ABEO's intrinsic value at $1.85, implying -74.7% downside from the current price. See which stocks rank higher →
How Does ABEO Rank in Biotechnology?
Among 76 Biotechnology stocks, ABEO ranks #24 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
As a biotech sector, Abeona Therapeutics Inc. operates in a sector where partnership revenue is a critical driver of valuation. Investors evaluating ABEO should weigh these sector-specific dynamics alongside our model-derived fair values.
Is ABEO a Value Trap?
CirclFi's Value Trap algorithm assigns ABEO a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Abeona Therapeutics Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Abeona Therapeutics Inc.'s fundamental quality profile registers 5.6/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +141.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ABEO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ABEO's 12 active models, average confidence is 27%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad